nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Doxorubicin—liver cancer	0.24	0.367	CbGbCtD
Tenofovir—ABCC4—Sorafenib—liver cancer	0.19	0.291	CbGbCtD
Tenofovir—ABCC2—Sorafenib—liver cancer	0.113	0.173	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—liver cancer	0.0687	0.105	CbGbCtD
Tenofovir—ABCC2—bile canaliculus—liver cancer	0.0534	0.487	CbGeAlD
Tenofovir—CYP1A2—Sorafenib—liver cancer	0.0422	0.0645	CbGbCtD
Tenofovir—ABCC2—bile duct—liver cancer	0.0167	0.152	CbGeAlD
Tenofovir—ABCC2—bile—liver cancer	0.0128	0.117	CbGeAlD
Tenofovir—NME2—embryo—liver cancer	0.00579	0.0528	CbGeAlD
Tenofovir—NME1-NME2—liver—liver cancer	0.00489	0.0445	CbGeAlD
Tenofovir—S-Adenosylmethionine—GNMT—liver cancer	0.00466	0.461	CrCbGaD
Tenofovir—Amylase increased—Sorafenib—liver cancer	0.00462	0.0398	CcSEcCtD
Tenofovir—Hypophosphataemia—Sorafenib—liver cancer	0.00379	0.0326	CcSEcCtD
Tenofovir—AK2—liver—liver cancer	0.0037	0.0338	CbGeAlD
Tenofovir—Lactic acidosis—Epirubicin—liver cancer	0.00333	0.0287	CcSEcCtD
Tenofovir—Lactic acidosis—Doxorubicin—liver cancer	0.00308	0.0265	CcSEcCtD
Tenofovir—Adenosine triphosphate—TNK2—liver cancer	0.00288	0.285	CrCbGaD
Tenofovir—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.00287	0.0247	CcSEcCtD
Tenofovir—NME1—liver—liver cancer	0.00284	0.0259	CbGeAlD
Tenofovir—AK4—liver—liver cancer	0.00274	0.025	CbGeAlD
Tenofovir—NME2—liver—liver cancer	0.00268	0.0244	CbGeAlD
Tenofovir—Proteinuria—Sorafenib—liver cancer	0.0025	0.0216	CcSEcCtD
Tenofovir—Rhabdomyolysis—Sorafenib—liver cancer	0.00249	0.0214	CcSEcCtD
Tenofovir—Protein urine present—Sorafenib—liver cancer	0.00247	0.0213	CcSEcCtD
Tenofovir—Renal failure acute—Sorafenib—liver cancer	0.00173	0.0149	CcSEcCtD
Tenofovir—Hypokalaemia—Sorafenib—liver cancer	0.00145	0.0125	CcSEcCtD
Tenofovir—Nasopharyngitis—Sorafenib—liver cancer	0.00143	0.0123	CcSEcCtD
Tenofovir—Hypophosphataemia—Epirubicin—liver cancer	0.0014	0.012	CcSEcCtD
Tenofovir—Pancreatitis—Sorafenib—liver cancer	0.00135	0.0117	CcSEcCtD
Tenofovir—Serum creatinine increased—Epirubicin—liver cancer	0.00132	0.0114	CcSEcCtD
Tenofovir—ABCC10—liver—liver cancer	0.0013	0.0118	CbGeAlD
Tenofovir—Hypophosphataemia—Doxorubicin—liver cancer	0.00129	0.0111	CcSEcCtD
Tenofovir—Weight decreased—Sorafenib—liver cancer	0.00125	0.0108	CcSEcCtD
Tenofovir—Pneumonia—Sorafenib—liver cancer	0.00124	0.0107	CcSEcCtD
Tenofovir—Infestation NOS—Sorafenib—liver cancer	0.00123	0.0106	CcSEcCtD
Tenofovir—Infestation—Sorafenib—liver cancer	0.00123	0.0106	CcSEcCtD
Tenofovir—Serum creatinine increased—Doxorubicin—liver cancer	0.00122	0.0105	CcSEcCtD
Tenofovir—Renal failure—Sorafenib—liver cancer	0.00121	0.0104	CcSEcCtD
Tenofovir—Neuropathy peripheral—Sorafenib—liver cancer	0.00121	0.0104	CcSEcCtD
Tenofovir—Hepatobiliary disease—Sorafenib—liver cancer	0.00116	0.01	CcSEcCtD
Tenofovir—Hepatomegaly—Epirubicin—liver cancer	0.00115	0.00989	CcSEcCtD
Tenofovir—Urinary tract disorder—Sorafenib—liver cancer	0.00109	0.0094	CcSEcCtD
Tenofovir—Connective tissue disorder—Sorafenib—liver cancer	0.00109	0.00935	CcSEcCtD
Tenofovir—Urethral disorder—Sorafenib—liver cancer	0.00108	0.00933	CcSEcCtD
Tenofovir—ABCC4—liver—liver cancer	0.00108	0.00983	CbGeAlD
Tenofovir—Hepatomegaly—Doxorubicin—liver cancer	0.00106	0.00915	CcSEcCtD
Tenofovir—ABCC2—liver—liver cancer	0.00104	0.00951	CbGeAlD
Tenofovir—Adenosine triphosphate—AKT1—liver cancer	0.00103	0.102	CrCbGaD
Tenofovir—Glycosuria—Epirubicin—liver cancer	0.001	0.00864	CcSEcCtD
Tenofovir—Immune system disorder—Sorafenib—liver cancer	0.000998	0.00859	CcSEcCtD
Tenofovir—Mediastinal disorder—Sorafenib—liver cancer	0.000996	0.00857	CcSEcCtD
Tenofovir—Adenosine triphosphate—ABL1—liver cancer	0.000974	0.0965	CrCbGaD
Tenofovir—Mental disorder—Sorafenib—liver cancer	0.000968	0.00834	CcSEcCtD
Tenofovir—Malnutrition—Sorafenib—liver cancer	0.000962	0.00828	CcSEcCtD
Tenofovir—Glycosuria—Doxorubicin—liver cancer	0.000929	0.008	CcSEcCtD
Tenofovir—Angioedema—Sorafenib—liver cancer	0.000879	0.00757	CcSEcCtD
Tenofovir—Creatinine increased—Epirubicin—liver cancer	0.000854	0.00736	CcSEcCtD
Tenofovir—Bone pain—Epirubicin—liver cancer	0.000849	0.00731	CcSEcCtD
Tenofovir—Arthralgia—Sorafenib—liver cancer	0.000819	0.00705	CcSEcCtD
Tenofovir—Myalgia—Sorafenib—liver cancer	0.000819	0.00705	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000813	0.007	CcSEcCtD
Tenofovir—Creatinine increased—Doxorubicin—liver cancer	0.00079	0.00681	CcSEcCtD
Tenofovir—Bone pain—Doxorubicin—liver cancer	0.000785	0.00676	CcSEcCtD
Tenofovir—Nervous system disorder—Sorafenib—liver cancer	0.00077	0.00663	CcSEcCtD
Tenofovir—Skin disorder—Sorafenib—liver cancer	0.000762	0.00657	CcSEcCtD
Tenofovir—Anorexia—Sorafenib—liver cancer	0.000748	0.00644	CcSEcCtD
Tenofovir—CYP1A2—liver—liver cancer	0.000732	0.00668	CbGeAlD
Tenofovir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000715	0.00616	CcSEcCtD
Tenofovir—Dyspnoea—Sorafenib—liver cancer	0.0007	0.00603	CcSEcCtD
Tenofovir—Dyspepsia—Sorafenib—liver cancer	0.000691	0.00595	CcSEcCtD
Tenofovir—Decreased appetite—Sorafenib—liver cancer	0.000682	0.00588	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Sorafenib—liver cancer	0.000678	0.00584	CcSEcCtD
Tenofovir—Fatigue—Sorafenib—liver cancer	0.000677	0.00583	CcSEcCtD
Tenofovir—Pain—Sorafenib—liver cancer	0.000671	0.00578	CcSEcCtD
Tenofovir—Gastrointestinal pain—Sorafenib—liver cancer	0.000642	0.00553	CcSEcCtD
Tenofovir—Renal failure acute—Epirubicin—liver cancer	0.000639	0.0055	CcSEcCtD
Tenofovir—Abdominal pain—Sorafenib—liver cancer	0.00062	0.00534	CcSEcCtD
Tenofovir—Body temperature increased—Sorafenib—liver cancer	0.00062	0.00534	CcSEcCtD
Tenofovir—Renal impairment—Epirubicin—liver cancer	0.00062	0.00534	CcSEcCtD
Tenofovir—Renal failure acute—Doxorubicin—liver cancer	0.000591	0.00509	CcSEcCtD
Tenofovir—Hypersensitivity—Sorafenib—liver cancer	0.000578	0.00498	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—liver cancer	0.000574	0.00494	CcSEcCtD
Tenofovir—Asthenia—Sorafenib—liver cancer	0.000563	0.00485	CcSEcCtD
Tenofovir—S-Adenosylmethionine—CYP2E1—liver cancer	0.000556	0.0551	CrCbGaD
Tenofovir—Pruritus—Sorafenib—liver cancer	0.000555	0.00478	CcSEcCtD
Tenofovir—Blood creatinine increased—Epirubicin—liver cancer	0.000553	0.00476	CcSEcCtD
Tenofovir—Hypokalaemia—Epirubicin—liver cancer	0.000537	0.00463	CcSEcCtD
Tenofovir—Diarrhoea—Sorafenib—liver cancer	0.000537	0.00462	CcSEcCtD
Tenofovir—Nasopharyngitis—Epirubicin—liver cancer	0.000528	0.00454	CcSEcCtD
Tenofovir—Muscular weakness—Epirubicin—liver cancer	0.000521	0.00448	CcSEcCtD
Tenofovir—Dizziness—Sorafenib—liver cancer	0.000519	0.00447	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—liver cancer	0.000512	0.00441	CcSEcCtD
Tenofovir—Pancreatitis—Epirubicin—liver cancer	0.0005	0.00431	CcSEcCtD
Tenofovir—Vomiting—Sorafenib—liver cancer	0.000499	0.0043	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—liver cancer	0.000497	0.00428	CcSEcCtD
Tenofovir—Rash—Sorafenib—liver cancer	0.000495	0.00426	CcSEcCtD
Tenofovir—Dermatitis—Sorafenib—liver cancer	0.000494	0.00426	CcSEcCtD
Tenofovir—Headache—Sorafenib—liver cancer	0.000492	0.00423	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—liver cancer	0.000488	0.00421	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—liver cancer	0.000482	0.00415	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Epirubicin—liver cancer	0.000474	0.00408	CcSEcCtD
Tenofovir—Nausea—Sorafenib—liver cancer	0.000466	0.00401	CcSEcCtD
Tenofovir—Pancreatitis—Doxorubicin—liver cancer	0.000463	0.00398	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—liver cancer	0.000461	0.00397	CcSEcCtD
Tenofovir—Hyperglycaemia—Epirubicin—liver cancer	0.00046	0.00396	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—liver cancer	0.000457	0.00394	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—liver cancer	0.000455	0.00392	CcSEcCtD
Tenofovir—Infestation—Epirubicin—liver cancer	0.000455	0.00392	CcSEcCtD
Tenofovir—Renal failure—Epirubicin—liver cancer	0.000447	0.00385	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—liver cancer	0.000446	0.00384	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000439	0.00378	CcSEcCtD
Tenofovir—Sweating—Epirubicin—liver cancer	0.000436	0.00375	CcSEcCtD
Tenofovir—Haematuria—Epirubicin—liver cancer	0.000434	0.00373	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—liver cancer	0.00043	0.0037	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—liver cancer	0.000427	0.00368	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—liver cancer	0.000427	0.00367	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—liver cancer	0.000426	0.00367	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—liver cancer	0.000423	0.00365	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—liver cancer	0.000421	0.00362	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—liver cancer	0.000421	0.00362	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—liver cancer	0.000414	0.00356	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—liver cancer	0.000413	0.00355	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—liver cancer	0.000408	0.00352	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—liver cancer	0.000403	0.00347	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—liver cancer	0.000403	0.00347	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—liver cancer	0.000401	0.00346	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—liver cancer	0.000401	0.00346	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—liver cancer	0.0004	0.00345	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—liver cancer	0.000398	0.00343	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—liver cancer	0.000395	0.0034	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—liver cancer	0.000378	0.00325	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—liver cancer	0.000373	0.00321	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—liver cancer	0.000371	0.0032	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—liver cancer	0.00037	0.00319	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—liver cancer	0.000369	0.00318	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—liver cancer	0.000368	0.00317	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—liver cancer	0.000358	0.00308	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—liver cancer	0.000355	0.00306	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—liver cancer	0.00035	0.00302	CcSEcCtD
Tenofovir—Back pain—Epirubicin—liver cancer	0.000344	0.00296	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—liver cancer	0.000341	0.00294	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—liver cancer	0.00034	0.00293	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—liver cancer	0.000331	0.00285	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—liver cancer	0.000329	0.00283	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—liver cancer	0.000324	0.00279	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—liver cancer	0.000318	0.00274	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—liver cancer	0.000303	0.00261	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—liver cancer	0.000303	0.00261	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—liver cancer	0.000303	0.00261	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—liver cancer	0.000302	0.0026	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000301	0.00259	CcSEcCtD
Tenofovir—Nervous system disorder—Epirubicin—liver cancer	0.000284	0.00245	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—liver cancer	0.000282	0.00243	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—liver cancer	0.00028	0.00241	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—liver cancer	0.00028	0.00241	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—liver cancer	0.00028	0.00241	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—liver cancer	0.00028	0.00241	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—liver cancer	0.000279	0.0024	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000278	0.00239	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—liver cancer	0.000277	0.00238	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000264	0.00228	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—liver cancer	0.000263	0.00227	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—liver cancer	0.000262	0.00226	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—liver cancer	0.000261	0.00225	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—liver cancer	0.000259	0.00223	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—liver cancer	0.000259	0.00223	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—liver cancer	0.000256	0.0022	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—liver cancer	0.000255	0.0022	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—liver cancer	0.000252	0.00217	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Epirubicin—liver cancer	0.00025	0.00216	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—liver cancer	0.00025	0.00215	CcSEcCtD
Tenofovir—Pain—Epirubicin—liver cancer	0.000248	0.00214	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000245	0.00211	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—liver cancer	0.000243	0.00209	CcSEcCtD
Tenofovir—Dyspnoea—Doxorubicin—liver cancer	0.000239	0.00206	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—liver cancer	0.000237	0.00204	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—liver cancer	0.000236	0.00203	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—liver cancer	0.000233	0.00201	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000232	0.002	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—liver cancer	0.000231	0.00199	CcSEcCtD
Tenofovir—Pain—Doxorubicin—liver cancer	0.00023	0.00198	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—liver cancer	0.000229	0.00197	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—liver cancer	0.000229	0.00197	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000219	0.00189	CcSEcCtD
Tenofovir—Hypersensitivity—Epirubicin—liver cancer	0.000214	0.00184	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—liver cancer	0.000212	0.00183	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—liver cancer	0.000212	0.00183	CcSEcCtD
Tenofovir—Asthenia—Epirubicin—liver cancer	0.000208	0.00179	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—liver cancer	0.000205	0.00177	CcSEcCtD
Tenofovir—Diarrhoea—Epirubicin—liver cancer	0.000198	0.00171	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—liver cancer	0.000198	0.0017	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—liver cancer	0.000193	0.00166	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—liver cancer	0.000192	0.00165	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—liver cancer	0.00019	0.00164	CcSEcCtD
Tenofovir—Vomiting—Epirubicin—liver cancer	0.000184	0.00159	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—liver cancer	0.000184	0.00158	CcSEcCtD
Tenofovir—Rash—Epirubicin—liver cancer	0.000183	0.00158	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—liver cancer	0.000183	0.00157	CcSEcCtD
Tenofovir—Headache—Epirubicin—liver cancer	0.000182	0.00156	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—liver cancer	0.000177	0.00153	CcSEcCtD
Tenofovir—Nausea—Epirubicin—liver cancer	0.000172	0.00148	CcSEcCtD
Tenofovir—Vomiting—Doxorubicin—liver cancer	0.000171	0.00147	CcSEcCtD
Tenofovir—Rash—Doxorubicin—liver cancer	0.000169	0.00146	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—liver cancer	0.000169	0.00146	CcSEcCtD
Tenofovir—Headache—Doxorubicin—liver cancer	0.000168	0.00145	CcSEcCtD
Tenofovir—Nausea—Doxorubicin—liver cancer	0.000159	0.00137	CcSEcCtD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00015	0.00137	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTA2—liver cancer	0.00015	0.00137	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—HGF—liver cancer	0.000149	0.00136	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—GSTM1—liver cancer	0.000149	0.00136	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000148	0.00136	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTP1—liver cancer	0.000147	0.00134	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTA1—liver cancer	0.000145	0.00133	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000145	0.00133	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000145	0.00133	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000145	0.00132	CbGpPWpGaD
Tenofovir—AK2—Metabolism—HMOX1—liver cancer	0.000145	0.00132	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000144	0.00131	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NAT2—liver cancer	0.000144	0.00131	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000143	0.00131	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PRKCE—liver cancer	0.000142	0.0013	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000138	0.00126	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALDOB—liver cancer	0.000138	0.00126	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000137	0.00125	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—HPGDS—liver cancer	0.000136	0.00124	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PSMA4—liver cancer	0.000135	0.00123	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTM1—liver cancer	0.000135	0.00123	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PSMD10—liver cancer	0.000135	0.00123	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—PPARA—liver cancer	0.000135	0.00123	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IGF2—liver cancer	0.000134	0.00123	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000134	0.00122	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP1A1—liver cancer	0.000134	0.00122	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.000134	0.00122	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.000134	0.00122	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000132	0.00121	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000132	0.0012	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CRABP1—liver cancer	0.000131	0.0012	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GOT2—liver cancer	0.000131	0.0012	CbGpPWpGaD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000129	0.00118	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP1A1—liver cancer	0.000128	0.00117	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000128	0.00117	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000128	0.00117	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—liver cancer	0.000127	0.00116	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—HGF—liver cancer	0.000127	0.00116	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000126	0.00115	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000126	0.00115	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.000126	0.00115	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000125	0.00114	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP2E1—liver cancer	0.000123	0.00113	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000122	0.00112	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000122	0.00112	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000122	0.00111	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	0.000121	0.00111	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000119	0.00109	CbGpPWpGaD
Tenofovir—AK2—Metabolism—MTHFR—liver cancer	0.000119	0.00109	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—NR1H4—liver cancer	0.000119	0.00109	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PPARA—liver cancer	0.000117	0.00107	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTA3—liver cancer	0.000117	0.00107	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—TGFB1—liver cancer	0.000117	0.00107	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000116	0.00106	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYCS—liver cancer	0.000115	0.00105	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	0.000115	0.00105	CbGpPWpGaD
Tenofovir—NME1—Metabolism—HPGDS—liver cancer	0.000115	0.00105	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GOT1—liver cancer	0.000113	0.00103	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GGT1—liver cancer	0.000113	0.00103	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	0.000111	0.00101	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SERPINA1—liver cancer	0.000111	0.00101	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.000111	0.00101	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000108	0.000987	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000108	0.000986	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.000107	0.000977	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000107	0.000974	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.000105	0.000963	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.000104	0.000952	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PSMD10—liver cancer	0.000102	0.000934	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PSMA4—liver cancer	0.000102	0.000934	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTP1—liver cancer	0.000102	0.00093	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.000102	0.000929	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK14—liver cancer	0.000102	0.000928	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000101	0.000918	CbGpPWpGaD
Tenofovir—NME2—Metabolism—HMOX1—liver cancer	0.0001	0.000917	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ALB—liver cancer	0.0001	0.000916	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CG—liver cancer	0.0001	0.000915	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GOT2—liver cancer	9.95e-05	0.000909	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—NAT2—liver cancer	9.94e-05	0.000908	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—F2—liver cancer	9.85e-05	0.0009	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	9.81e-05	0.000896	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PPARG—liver cancer	9.67e-05	0.000883	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	9.43e-05	0.000861	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTM1—liver cancer	9.35e-05	0.000854	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP2E1—liver cancer	9.35e-05	0.000854	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—CTNNB1—liver cancer	9.33e-05	0.000852	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTP1—liver cancer	9.13e-05	0.000834	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—RAF1—liver cancer	9.07e-05	0.000828	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP1A1—liver cancer	8.87e-05	0.00081	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CD—liver cancer	8.81e-05	0.000804	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	8.76e-05	0.0008	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYCS—liver cancer	8.75e-05	0.000799	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ALB—liver cancer	8.7e-05	0.000794	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GGT1—liver cancer	8.59e-05	0.000784	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GOT1—liver cancer	8.59e-05	0.000784	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTM1—liver cancer	8.39e-05	0.000767	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	8.34e-05	0.000761	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	8.29e-05	0.000757	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA1—liver cancer	8.27e-05	0.000755	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MTHFR—liver cancer	8.27e-05	0.000755	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	8.22e-05	0.000751	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	8.2e-05	0.000749	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—ALB—liver cancer	8.18e-05	0.000747	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PPARA—liver cancer	8.11e-05	0.000741	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—HPGDS—liver cancer	7.95e-05	0.000726	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTP1—liver cancer	7.71e-05	0.000704	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CB—liver cancer	7.68e-05	0.000701	CbGpPWpGaD
Tenofovir—NME1—Metabolism—HMOX1—liver cancer	7.61e-05	0.000695	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—liver cancer	7.56e-05	0.00069	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	7.53e-05	0.000688	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	7.53e-05	0.000688	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	7.49e-05	0.000684	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—RAF1—liver cancer	7.4e-05	0.000676	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	7.37e-05	0.000673	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	7.35e-05	0.000671	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PRKCE—liver cancer	7.31e-05	0.000668	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	7.29e-05	0.000666	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	7.22e-05	0.00066	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFB1—liver cancer	7.21e-05	0.000658	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	7.17e-05	0.000655	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTM1—liver cancer	7.09e-05	0.000647	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—CYCS—liver cancer	6.99e-05	0.000639	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ABL1—liver cancer	6.96e-05	0.000636	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	6.95e-05	0.000635	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CG—liver cancer	6.95e-05	0.000634	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF2—liver cancer	6.93e-05	0.000633	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1A1—liver cancer	6.72e-05	0.000614	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PPARG—liver cancer	6.7e-05	0.000612	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—liver cancer	6.63e-05	0.000606	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HGF—liver cancer	6.54e-05	0.000598	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP2E1—liver cancer	6.48e-05	0.000592	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CSF2—liver cancer	6.47e-05	0.000591	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	6.39e-05	0.000584	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	6.34e-05	0.000579	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MTHFR—liver cancer	6.26e-05	0.000572	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	6.26e-05	0.000572	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	6.25e-05	0.000571	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PPARA—liver cancer	6.15e-05	0.000561	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CD—liver cancer	6.11e-05	0.000558	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	6.09e-05	0.000556	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—HMOX1—liver cancer	6.08e-05	0.000555	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB1—liver cancer	6.08e-05	0.000555	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ALB—liver cancer	6.03e-05	0.00055	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GGT1—liver cancer	5.95e-05	0.000543	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—CYCS—liver cancer	5.9e-05	0.000539	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	5.76e-05	0.000526	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	5.75e-05	0.000525	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—liver cancer	5.64e-05	0.000515	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	5.37e-05	0.00049	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	5.37e-05	0.00049	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTP1—liver cancer	5.34e-05	0.000488	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	5.32e-05	0.000486	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CB—liver cancer	5.32e-05	0.000486	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	5.29e-05	0.000483	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	5.27e-05	0.000481	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CG—liver cancer	5.26e-05	0.000481	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK14—liver cancer	5.24e-05	0.000479	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—liver cancer	5.17e-05	0.000473	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—HMOX1—liver cancer	5.13e-05	0.000468	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	5.12e-05	0.000468	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PPARG—liver cancer	5.08e-05	0.000464	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—F2—liver cancer	5.08e-05	0.000464	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—PPARA—liver cancer	4.91e-05	0.000449	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—liver cancer	4.91e-05	0.000448	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CG—liver cancer	4.86e-05	0.000444	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	4.84e-05	0.000442	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	4.74e-05	0.000433	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—liver cancer	4.68e-05	0.000427	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1A1—liver cancer	4.66e-05	0.000425	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CD—liver cancer	4.63e-05	0.000423	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	4.59e-05	0.000419	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALB—liver cancer	4.57e-05	0.000417	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	4.57e-05	0.000417	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	4.53e-05	0.000413	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	4.4e-05	0.000402	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	4.28e-05	0.00039	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CD—liver cancer	4.27e-05	0.00039	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SERPINE1—liver cancer	4.22e-05	0.000386	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ALB—liver cancer	4.22e-05	0.000385	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—PPARA—liver cancer	4.14e-05	0.000378	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CB—liver cancer	4.03e-05	0.000368	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—liver cancer	3.82e-05	0.000349	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RAF1—liver cancer	3.81e-05	0.000348	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	3.81e-05	0.000348	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CB—liver cancer	3.72e-05	0.00034	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ALB—liver cancer	3.65e-05	0.000333	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.6e-05	0.000329	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	3.49e-05	0.000319	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UGDH—liver cancer	3.48e-05	0.000318	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	3.44e-05	0.000314	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—liver cancer	3.42e-05	0.000312	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—RAF1—liver cancer	3.3e-05	0.000301	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—EPT1—liver cancer	3.27e-05	0.000299	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—liver cancer	3.24e-05	0.000296	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	3.18e-05	0.00029	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TAT—liver cancer	3.1e-05	0.000283	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ALB—liver cancer	3.08e-05	0.000281	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.05e-05	0.000279	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—liver cancer	2.91e-05	0.000265	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	2.87e-05	0.000262	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—RAF1—liver cancer	2.78e-05	0.000254	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB1—liver cancer	2.67e-05	0.000244	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—liver cancer	2.65e-05	0.000242	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—liver cancer	2.47e-05	0.000226	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—liver cancer	2.46e-05	0.000225	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.28e-05	0.000209	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—liver cancer	2.27e-05	0.000207	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—liver cancer	2.2e-05	0.000201	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CPT1B—liver cancer	2.11e-05	0.000193	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GLUL—liver cancer	2.11e-05	0.000193	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—liver cancer	2.1e-05	0.000192	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NR1H4—liver cancer	2.03e-05	0.000186	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—liver cancer	2.01e-05	0.000183	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA3—liver cancer	2e-05	0.000183	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—liver cancer	1.85e-05	0.000169	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA4—liver cancer	1.83e-05	0.000167	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.79e-05	0.000163	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA2—liver cancer	1.78e-05	0.000163	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA1—liver cancer	1.72e-05	0.000157	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NAT2—liver cancer	1.7e-05	0.000155	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.63e-05	0.000149	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALDOB—liver cancer	1.63e-05	0.000149	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CRABP1—liver cancer	1.56e-05	0.000142	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.4e-05	0.000128	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HPGDS—liver cancer	1.36e-05	0.000124	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.35e-05	0.000123	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.23e-05	0.000112	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.22e-05	0.000111	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PSMA4—liver cancer	1.21e-05	0.000111	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PSMD10—liver cancer	1.21e-05	0.000111	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GOT2—liver cancer	1.18e-05	0.000108	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP2E1—liver cancer	1.11e-05	0.000101	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.07e-05	9.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYCS—liver cancer	1.04e-05	9.47e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GGT1—liver cancer	1.02e-05	9.29e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GOT1—liver cancer	1.02e-05	9.29e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTP1—liver cancer	9.14e-06	8.35e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HMOX1—liver cancer	9.01e-06	8.23e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—liver cancer	8.4e-06	7.67e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1A1—liver cancer	7.96e-06	7.27e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTHFR—liver cancer	7.42e-06	6.78e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPARA—liver cancer	7.28e-06	6.65e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.54e-06	5.97e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CG—liver cancer	6.24e-06	5.69e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPARG—liver cancer	6.02e-06	5.5e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CD—liver cancer	5.48e-06	5.01e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALB—liver cancer	5.41e-06	4.94e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CB—liver cancer	4.78e-06	4.36e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—liver cancer	2.91e-06	2.66e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—liver cancer	2.38e-06	2.17e-05	CbGpPWpGaD
